Whether the pandemic begins in Africa, Southeast Asia, or Europe, scientists will face the same challenge: they must develop a vaccine to help contain the disease. Vaccines have been the primary line of defence since 1796, when first used in the fight against smallpox. It worked, and few people today have experienced the devastating effects of smallpox, which once killed hundreds of thousands of people annually but has been all but eradicated. Nor have we seen victims of polio, who were once enclosed in iron lungs. Yet something is changing rapidly in the submicroscopic world of viruses, and new threats are beginning to appear with startling frequency. Almost thirty diseases have emerged to target humans over the past three decades, including Sudden Acute Respiratory Syndrome (sars), West Nile, bse (“mad cow” disease), hiv-aids, Hepatitis C, and the Nipah virus, which causes encephalitis and acute respiratory problems. They all travelled a long evolutionary path before crossing the species barrier to become human diseases, and they signal a troubling trend: close to 80 percent of all new or re-emerging diseases are zoonotic — meaning they are transmitted from animals to humans.
Like a human, a virus’s aspirations are quite simple: it wants to survive and multiply. To do so it requires a host cell where it can replicate. But its presence among us raises a number of questions that scientists cannot yet fully answer, notably how do viruses spread to different species, and particularly how did avian influenza become so dangerous to birds and capable of killing half the humans it infects?
Humans, either in the course of fighting an infection or in response to a vaccination, develop antibodies. These are the soldiers of the immune system, battling infection and neutralizing viruses so that only those that have mutated can escape. For a vaccine to be effective, it must contain exact matches to the surface proteins of the virus it is working to control. But a virus’s own survival mechanisms can defeat antibodies by undergoing what scientists call antigenic drift, by which specific surface proteins (in the case of influenza, hemagglutinin-H or neuraminidase-N) change very slightly.
If antigenic drift is the small-arms fire the virus uses to defeat the immune system, antigenic shift is the grenade launcher. Antigenic shift occurs when there is a dramatic change in the virus’s genetic makeup — such as the one that transforms an animal virus into a human virus. In these instances, the virus acquires an entirely new gene from a different virus altogether. It is usually a related animal influenza virus and consequently contains new surface proteins (H, N, or both). Animals, especially birds, have a large number of variants of the H and N gene. Each variation is given a number: H1, H2, H3, for example, or N1, N2, N3, and so on. Hence the h5n1 strain of avian influenza virus that is currently preoccupying health officials around the world.
These viruses aren’t necessarily harmful. Normally they remain within the migratory bird population causing minimal disease; last fall a number of h5 influenza viruses were found in healthy Canadian ducks. But they can mutate to become virulent. The current h5n1 avian influenza virus does not discriminate between humans and birds. Fortunately, many of these avian viruses, including h5n1, are not very good at infecting humans. So far avian influenza has been found in only about 130 people living primarily in Southeast Asia — despite the fact that there have been outbreaks of bird flu in fifteen countries.
The h5n1 virus becomes far more dangerous when it infects a person who also has a human influenza virus. It can quickly recombine the genes from the human and animal virus to create a virus that contains the genes of both, and in so doing gain the ability to move not just from birds to humans, but between humans. Since this is a completely new virus, humans do not have any pre-existing immunity to it.
Why have many of the pandemics of the past century, including the Hong Kong flu in 1968, had their origins in Asia? It is likely because Asia has a large number of both domestic and wild bird populations living in close contact. This exposes do- mestic birds to the entire spectrum of influenza viruses living in migratory birds, especially ducks. Mammals such as pigs, which are also often found in the same environment as domestic and wild birds, can act as “mixing vessels” for bird and mammal viruses.
One thing that struck me during my travels in Asia was that vast numbers of ducks, both wild and domestic, shared the same farm ponds, which children play near or swim in. Since the viruses from the wild ducks were in the water, the domestic ducks could easily be infected. Similarly, humans exposed to the water or to the ducks could be infected. The problem is not restricted just to farms: humans are also exposed to the viruses at live animal markets, where large numbers of city dwellers shop on a daily basis.











Comments